This neoplasm is not reportable.
Name
Angioimmunoblastic lymphadenopathy
ICD-O-2 Morphology
9767/1: Angioimmunoblastic lymphadenopathy
Effective
1992 - 2000
ICD-O-3 Morphology
9767/1: Angioimmunoblastic lymphadenopathy
Effective
2001 and later
Reportability
This neoplasm is not reportable
Primary Site(s)
See Abstractor Notes
This neoplasm is reportable for primary sites C700-C729, C751-C753 only.
Abstractor Notes
If the diagnosis is angioimmunoblastic lymphadenopathy assign 9767/1. If the dx is angioimmunoblastic lymphadenopathy with dysprotenemia, assign to 9705/3.
Alternate Names
AIL
Immunoblastic lymphadenopathy (IBL) [OBS]
Corresponding ICD-9 Codes
238.79 Other lymphatic and hematopoietic tissues
Corresponding ICD-10 Codes
D47.7 Other specified neoplasms of uncertain or unknown behavior of lymphoid, hematopoietic, and related tissue
Corresponding ICD-10-CM Codes (U.S. only)
D47.Z9 Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue (effective October 01, 2015)
Sources
International Classification of Diseases for Oncology, Third Edition, Second Revision. Geneva: World Health Organization, 2020.
Section: ICD-O-3.2 (2020) Morphological Codes
Pages: http://www.iacr.com.fr/index.php?option=com_content&view=category&layout=blog&id=100&Itemid=577
Section: ICD-O-3.2 (2020) Morphological Codes
Pages: http://www.iacr.com.fr/index.php?option=com_content&view=category&layout=blog&id=100&Itemid=577